Chardan Capital raised their FY2025 earnings estimates for shares of Solid Biosciences in a research report issued to clients and investors on Wednesday, February 19th. Chardan Capital analyst Y.

Candel Therapeutics Inc. shares gained momentum as Wall Street analysts highlighted the potential of its lead cancer drug ...

Equities researchers at StockNews.com initiated coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a report released on Saturday. The brokerage set a “sell” rating on the ...

Ubee Interactive Holding Corp. (hereinafter referred to as "Ubee") officially announces that by resolution of the Board of Directors, Mr. Robert Mao has been appointed as the new Chairman, and Dr. Lin ...

Tinubu, APC leaders have settled on the removal of both Obasa and Meranda as House Speakers to solve the Lagos Assembly ...

B&H is pleased to share, Sigma is getting an early start on CP+ with the launch featuring a brand-new mirrorless camera, two new zoom lenses, and a re-release of the much-loved I series of compact ...

Union minister Jitendra Singh on Sunday held a meeting with newly elected BJP legislators here to discuss the strategy for the Budget Session of the Jammu and Kashmir Assembly which is scheduled to ...

Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...